NCT04662281: An ongoing trial by Lexicon Pharmaceuticals
This trial is completed, but has been granted a delay in reporting its results.
It must report results 3 weeks, 5 days from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04662281 |
|---|---|
| Title | A Phase 2, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX9211 in the Treatment of Postherpetic Neuralgia (RELIEF-PHN1) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 29, 2020 |
| Completion date | Nov. 18, 2022 |
| Required reporting date | Nov. 18, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Sept. 16, 2025 |
| Days late | None |